![]() | |
| Clinical data | |
|---|---|
| Trade names | Akrinor, Bifort, Praxinor |
| Other names | Caphedrine; Cafedrin; Caphedrin; Kafedrin; Norephedrino-ethyltheophylline; 7-(2-(β-Hydroxy-α-methylphen-ethylamino)ethyl)theophylline |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H23N5O3 |
| Molar mass | 357.414 g·mol−1 |
| 3D model (JSmol) | |
| |
| | |
Cafedrine (INNTooltip International Nonproprietary Name, BANTooltip British Approved Name), sold under the brand name Akrinor among others, is a chemical linkage of norephedrine and theophylline and is a cardiac stimulant and antihypotensive agent used to increase blood pressure in people with hypotension.1234 It has been marketed in Europe, South Africa, and Indonesia.45
There has been concern about cafedrine as a potential performance-enhancing drug and doping agent in sports.6
References
References
- Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 205. ISBN 978-1-4757-2085-3. Retrieved 29 August 2024.
- Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. Elsevier Science. 2013. p. 785. ISBN 978-0-8155-1856-3. Retrieved 29 August 2024.
- Morton IK, Hall JM (1999). "Calcitonin gene-related peptide receptor antagonist". Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Dordrecht: Springer Netherlands. p. 59. ISBN 9789401144391.
- Schweizerischer Apotheker-Verein (2000). Index Nominum 2000: International Drug Directory. Medpharm Scientific Publishers. p. 157. ISBN 978-3-88763-075-1. Retrieved 29 August 2024.
- "Cafedrine". Drugs.com. Archived from the original on 6 January 2018. Retrieved 29 August 2024.
{{cite web}}: CS1 maint: bot: original URL status unknown (link) - Wilson W, Derse E (2001). Doping in Elite Sport: The Politics of Drugs in the Olympic Movement. Human Kinetics. p. 15. ISBN 978-0-7360-0329-2. Retrieved 29 August 2024.
